Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Slovakia
Slovakia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 96.0% in 2024. ▬ Flat
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Slovakia, 2009–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
The most recent figure for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Slovakia is 96.0%, measured in 2024. That is the lowest value across all 16 years on record.
Compared with earlier readings it is down 1.0% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Slovakia peaked at 99.0% in 2009 and was at its lowest, 96.0%, in 2015.
That places Slovakia 15th out of 146 countries with data for 2024, putting it in the top 10%.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Slovakia, year by year
| Year | % | Change |
|---|---|---|
| 2009 | 99.0% | — |
| 2010 | 99.0% | +0.0% |
| 2011 | 99.0% | +0.0% |
| 2012 | 99.0% | +0.0% |
| 2013 | 98.0% | -1.0% |
| 2014 | 97.0% | -1.0% |
| 2015 | 96.0% | -1.0% |
| 2016 | 96.0% | +0.0% |
| 2017 | 96.0% | +0.0% |
| 2018 | 96.0% | +0.0% |
| 2019 | 97.0% | +1.0% |
| 2020 | 96.0% | -1.0% |
| 2021 | 97.0% | +1.0% |
| 2022 | 96.0% | -1.0% |
| 2023 | 96.0% | +0.0% |
| 2024 | 96.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 99.0% | 99.0% | 99.0% | 1 |
| 2010s | 97.3% | 96.0% | 99.0% | 10 |
| 2020s | 96.2% | 96.0% | 97.0% | 5 |
Countries ranked near Slovakia
More health data for Slovakia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9332 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,433 deaths per 1,000 people (2090)
- Number of infants who die before age 1 28 deaths (2100)
- Population ages 75-79, female, annual growth rate 6.4 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0225 units per person (2025)
- Population ages 75-79, male, annual growth rate 8.23 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0143 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Slovakia?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Slovakia was 96.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Slovakia?
- The highest recorded value was 99.0% in 2009.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Slovakia?
- The lowest recorded value was 96.0% in 2015.
- How does Slovakia rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Slovakia ranks 15th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Slovakia?
- Over the last ten years it is down 1.0%. The long-run trend across the full record is flat.
- Where does this Slovakia data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.